WST - West Pharmaceutical Services Inc P/S Multiple

Corporate company logo of West Pharma Corp (WST)

Demand for FluroTec components for obesity drugs is driving growth, and consequently, the P/S history on GURU.Markets shows the current value is 8.60. West Pharmaceutical Services (WST) relies on stringent FDA requirements for sterile packaging, creating significant barriers to entry for competitors. The company's monopolization of the injectable vial and stopper market secures its unique position within the biopharmaceutical sector.

WST West Pharmaceutical Services Inc: P/S Multiple in the range 07/04/2022 - 11/15/2026

West Pharmaceutical Services Inc (WST) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart West Pharmaceutical Services Inc|WST - Consensus Target
- market capitalization statistics:
Market Capitalization West Pharmaceutical Services|WST - Total Company Value
- balance sheet equity data:
Accounting Value per Share West Pharmaceutical Services|WST - Book Capitalization|Market-to-Book Ratio westpharma.com|WST - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Ratio West Pharmaceutical Services|WST - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio westpharma.com|WST - Company Debts|Debts to Net Assets West Pharmaceutical Services, Inc.|WST - Company Long-Term Liabilities|Company Current Liabilities West Pharmaceutical Services|Immediate Liquidity westpharma.com
- business earnings and investment ratios data:
WST - Company Net Income|Company Profit Forecast West Pharmaceutical Services|WST - Price to Earnings Ratio|Market Cap to Future Earnings Ratio West Pharmaceutical Services|WST - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation West Pharmaceutical Services|WST - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months West Pharmaceutical Services|WST - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months westpharma.com|WST - Earnings growth in current year|Earnings growth forecast for next year West Pharmaceutical Services
- issuer revenue and sales details:
WST - Company Revenue|Company Future Revenue West Pharma|WST - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple West Pharma Corp|WST - Sales Growth YoY (TTM)
Fundamental company analysis:WST, West Pharmaceutical Services Inc
Manufactured products of West Pharma

The selection of high-quality issuers is based on comparing market capitalization with actual sales volume to determine the fair value of the business. The P/S ratio measures the price per unit of revenue, which in the case of West Pharmaceutical Services (WST) allows for an assessment of the monetization efficiency of robotic component sterilization lines through an analysis of this chart's price action.

Who West Pharmaceutical Services competes with

Market Cap to Sales Volume ISRG|Danaher Corporation - Market Cap to Revenue|P/S Multiple Becton Dickinson & Company BDX|STE - Price-to-Revenue Ratio|Baxter International (BAX) - Market Cap to Revenue|Masimo Corp (MASI) - Price-to-Revenue Ratio|Market Cap to Revenue Stevanato Group|Price-to-Revenue Ratio Teleflex Incorporated|Price to Sales Merit Medical Corp MMSI|Price-to-Revenue Ratio Envista (NVST)|ICU Medical - Market Cap to Revenue Ratio|DENTSPLY SIRONA Inc. - Market Cap to Revenue|Market Cap to Sales Volume LMAT (LeMaitre Vascular Inc)|ATRC - Price-to-Revenue Ratio|Price-to-Revenue Coefficient STAAR Surgical Co STAA|NAGE: P/S Multiple|Price-to-Sales Ratio ZIMV (ZimVie Inc.)|Price-to-Revenue Ratio AngioDynamics Corp|Price to Sales Cerus Corp. CERS|Price-to-Revenue Ratio Teknova (TKNO)|Monogram Orthopedics Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Sharps Technology, Inc. STSS|P/S Multiple InfuSystem Holdings INFU|UTMD: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio KRMD (KORU Medical)|NYXH: P/S Multiple|MBOT (Microbot Medical, Inc) - Price-to-Revenue Ratio|Market Cap to Revenue PDEX|ZTEK: Market Capitalization-to-Revenue Ratio|P/S Multiple ELUT|Milestone Scientific Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NEXGEL, Inc. NXGL|Retractable Tech - Price-to-Revenue Ratio|harvardbioscience.com - P/S Multiple|FEMY (Femasys Inc.) - Market Cap to Revenue Ratio|MHUA: P/S Multiple|Predictive Oncology Corp - Market Capitalization-to-Revenue Ratio|CJMB (Callan JMB) - P/S Multiple|Price to Sales Atrion Corporation Inc. ATRI|P/S Multiple NURO